PedAM
Pediatric Disease Annotations & Medicines
| Disease | myocardial infarction |
| Phenotype | |diabetes |
| Sentences | 128 |
| PubMedID- 20157205 | It was found that 178 (52.4%) patients with type 2 diabetes had law risk of development of myocardial infarction, 89 (26.2%) patients - moderate and 73 patients (21.4%) - the high risk of myocardial infarction. |
| PubMedID- PMC3952941 | Exclusion criteria were clinical coronary artery disease, chronic renal disease, diabetes mellitus, hypertension, history of myocardial infarction, angina pectoris or cerebrovascular disease, dyslipidemia, metabolic syndrome or active infection. |
| PubMedID- 24843443 | Furthermore, anemia is accompanied by cardiovascular events9–12, mortality13 and mortality after acute myocardial infarction16 in patients with diabetes mellitus. |
| PubMedID- 25790544 | Materials and methods: a total of 100 type 2 diabetes patients with myocardial infarction and 50 normal individuals were selected for this analysis. |
| PubMedID- 22763393 | In particular, further studies focusing on the risk of acute myocardial infarction in patients with diabetes treated with intravitreal vascular endothelial growth factor inhibitors are warranted. |
| PubMedID- 21539643 | Heart rate turbulence can predict cardiac mortality following myocardial infarction in patients with diabetes mellitus. |
| PubMedID- 24529823 | Glycemic variability predicts cardiovascular complications in acute myocardial infarction patients with type 2 diabetes mellitus. |
| PubMedID- 20158090 | Thus, pioglitazone reduced the composite of all-cause mortality, non-fatal myocardial infarction, and stroke in patients with type 2 diabetes who have a high risk of macrovascular events. |
| PubMedID- 23148342 | When considering gender, age, education, obesity, diabetes and history of myocardial infarction or hf, the discrimination to distinguish a third class increased mainly as a result of the reclassification of around a quarter of participants initially classified as non-cases into class 2, supporting the importance of including concomitant variables when judging the value of symptoms and signs of hf. |
| PubMedID- 22498999 | Cardiac remodeling and heart failure after a first anterior myocardial infarction in patients with diabetes mellitus. |
| PubMedID- 24095940 | Risk factors for cardiovascular diseases (hypertension, diabetes, dyslipidaemia, family history of myocardial infarction or sudden death), risk factors for infectious diseases and vaccination status, risk factors for cancers (family history of prostate, breast or colon cancer; adenomatosus polyposis and/or personal history of inflammatory bowel disease (for colon cancer) and history of numerous (>40) nevi for skin cancer). |
| PubMedID- 23459575 | Prevalence, incidence, and implications of silent myocardial infarctions in patients with diabetes mellitus. |
| PubMedID- 23286208 | Furthermore, short- and long-term survival following a myocardial infarction is lower in patients with type 2 diabetes mellitus compared to those without[4-8]. |
| PubMedID- 26279482 | Aims: to assess the risk of acute myocardial infarction (ami) in patients with type 2 diabetes mellitus treated with long-acting insulin analogues in comparison with other basal insulin therapy. |
| PubMedID- 23097721 | In the prospective pioglitazone clinical trial in macrovascular events (proactive) study, however, improved glycemic control with pioglitazone reduced the composite endpoint of all-cause mortality, nonfatal myocardial infarction, and stroke in patients with type-2 diabetes and atherosclerosis [6]. |
| PubMedID- 22436146 | Importantly, the study population only included persons at risk for myocardial infarction (persons with hypertension, diabetes mellitus and/or dyslipidemia) and "healthy user" bias possibly occurred in selecting controls [19,20]. |
| PubMedID- 20594348 | Data were acquired from human plasma obtained from a) an individual with congestive heart failure, diabetes, and a history of myocardial infarction (4.5% native form), and b) a healthy individual (66% native form). |
| PubMedID- 25078899 | Low adiponectin levels and increased risk of type 2 diabetes in patients with myocardial infarction. |
| PubMedID- 23270530 | Showed that acute myocardial infarction (mi) patients with igt or diabetes exhibited higher levels of high-sensitivity c-reactive protein and interleukin-6 levels compared with acute mi patients with normal glucose tolerance or well-controlled diabetes, indicating that glycol metabolism in acute mi is associated with acute stress and inflammation[26]. |
| PubMedID- 19395095 | Aims: the presence of diabetes mellitus (dm) in patients with myocardial infarction (mi) increases mortality, due in part to the presence of known cardiovascular risk factors. |
| PubMedID- 22815296 | Over the last decades, the prevalence of diabetes in patients with a myocardial infarction (mi) has increased significantly (1–3). |
| PubMedID- 25356815 | Exclusion criteria were age less than 35 years, type 1 diabetes mellitus, ecg evidence of q-wave myocardial infarction, ischemic st-segment or t-wave changes, or complete left-bundle branch block, a clinical history of cv disease, cerebrovascular disease, or malignancy, and an estimated modification of diet in renal disease gfr less than 60 ml/min/1.73 m2. |
| PubMedID- 24399329 | Risk of ischemic stroke after an acute myocardial infarction in patients with diabetes mellitus. |
| PubMedID- 26209521 | Low concentrations of serum testosterone predict acute myocardial infarction in men with type 2 diabetes mellitus. |
| PubMedID- 20205960 | Hospital admissions by acute myocardial infarction among subjects with or without diabetes for years 2001-2006. |
| PubMedID- 26151031 | Ros are generally regarded as a final common pathway for cell death and are elicited by all manner of tissue insults, such as diabetes-induced complications, ischemia associated with myocardial infarction or stroke, inflammatory stimuli such as endotoxin, and many anticancer drugs. |
| PubMedID- 21736547 | Furthermore, meta-analysis of seven long-term studies suggested that acarbose reduced the risk of myocardial infarction for patients with type 2 diabetes [137]. |
| PubMedID- 25411597 | These results might be clinically meaningful if the levels could be maintained long term, as it has been reported that a reduction of hba1c by 1% has been associated with a 21% reduction in the relative risk of death, 37% reduction in risk of microvascular complications and 14% reduction in risk of myocardial infarction15 in patients with type 2 diabetes mellitus. |
| PubMedID- 22462016 | Cardioprotective effect of liraglutide in comparison to metformin was showed in induced myocardial infarction in animals with diabetes, when similar metabolic control was achieved. |
| PubMedID- 22761919 | Twenty-six percent had hypercholesterolemia, 6.1% diabetes, 1.9% a history of myocardial infarction. |
| PubMedID- 23635324 | In the cardiovascular inflammation reduction trial (cirt) low dose methotrexate (target dose 20 mg/week) is tested for reduction of major cvd events among post-myocardial infarction patients with diabetes or metabolic syndrome[104]. |
| PubMedID- 22439599 | Reported that bezafibrate significantly decreased the combined incidence of ischemic change in ecg and documented myocardial infarction in patients with type 2 diabetes [37]. |
| PubMedID- 25918532 | His family history was positive for cataract and glaucoma (father), diabetes (brother of mother), and myocardial infarction (mother). |
| PubMedID- 26386939 | This study evaluated the association between sulfonylurea use and infarct size in diabetes patients with st-elevation myocardial infarction (stemi). |
| PubMedID- 20478050 | More data are required not only for efficacy, but also to address the long-term safety of rosiglitazone in these patients, particularly in light of the recent report that rosiglitazone is associated with a significant increase in the risk of myocardial infarction in patients with type 2 diabetes mellitus [55]. |
| PubMedID- 22247898 | The case fatality rate after myocardial infarction is higher in patients with diabetes than in patients without diabetes [18]. |
| PubMedID- 21386989 | C. further adjusted for systolic blood pressure, blood pressure lowering medication, total and hdl cholesterol, diabetes, history of myocardial infarction, history of congestive heart failure, serum potassium (continuous), and serum calcium (continuous). |
| PubMedID- 25147705 | In a multicenter, randomized, double- blind, and prospective trial, atorvastatin had no statistically significant effect on the composite primary end point of cardiovascular death, nonfatal myocardial infarction, and stroke in patients with diabetes receiving hemodialysis. |
| PubMedID- 22837677 | The risk of myocardial infarction in patients with diabetes and no history of cardiac disease roughly equates the risk in non-diabetic patients with known cardiac diseases [5]. |
| PubMedID- 22211855 | No differences were found in symptoms of myocardial infarction between women with and without diabetes or between men with and without diabetes. |
| PubMedID- 23651827 | Using a cox proportional hazard model, age, diabetes, history of stroke and myocardial infarction and vitamin e serum levels (hr 0.77; 95% ci: 0.67-0.89; p=0.001) independently predicted cardiovascular events. |
| PubMedID- 20809989 | The aims of the present study were to assess a potential association between circulating levels of inflammatory markers and hyperglycaemia measured during an acute st-elevation myocardial infarction (stemi) in patients without known diabetes, and to determine whether circulating levels of inflammatory markers measured early after an acute stemi, were associated with the presence of abnormal glucose regulation classified by an oral glucose tolerance test (ogtt) at three-month follow-up in the same cohort. |
| PubMedID- 24124429 | [3] notably, the risk of myocardial infarction (mi) in patients with type 2 diabetes with no previous history of coronary heart disease is similar to that among patients without diabetes who have already had mi. |
| PubMedID- 21562320 | Incidence and prevalence of unrecognized myocardial infarction in people with diabetes: a substudy of the rosiglitazone evaluated for cardiac outcomes and regulation of glycemia in diabetes (record) study. |
| PubMedID- 24619127 | myocardial infarction) in persons with type 2 diabetes who are exposed to air pollution [5], [15]. |
| PubMedID- 23226370 | Background: although the clinical outcome of acute myocardial infarction (ami) in patients with type 2 diabetes mellitus (t2dm) is well established to be worse than for non-diabetic patients, the reasons for this remain unclear. |
| PubMedID- 21760680 | Subjects experiencing scd were significantly more likely to have hypertension, diabetes and a history of myocardial infarction/coronary artery disease (p<0.01 for all). |
| PubMedID- 20083247 | Impact of diabetes on survival in patients with st-segment elevation myocardial infarction treated by primary angioplasty: insights from the polish stemi registry. |
| PubMedID- 24374422 | Conclusions: both overall pss and cvd subgroup-specific pss achieved good balance on measured covariates when assessing the relative association of diabetes monotherapy with nonfatal myocardial infarction. |
| PubMedID- 24660315 | Objective: to evaluate if patient characteristics would have significant effects on outcomes for inpatients' myocardial infarction (mi) with type 2 diabetes (t2d) admitted to non-federal hospitals. |